Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELAZOP Switching Study in Korea
NCT01055366Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Mar 2010
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of brinzolamide in open-angle glaucoma (OAG), ocular hypertension, pigmentary glaucoma (PG), sponsored by Alcon Inc.. Started Mar 2010; status: completed.
02
Drugs
brinzolamide
03
Conditions
open-angle glaucoma (OAG)ocular hypertensionpigmentary glaucoma (PG)
Beyond the preview
Go deeper on NCT01055366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01055366.